KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Inovio Pharmaceuticals (INO) FCF Margin (2016 - 2025)

Historic FCF Margin for Inovio Pharmaceuticals (INO) over the last 17 years, with Q1 2025 value amounting to 41218.49%.

  • Inovio Pharmaceuticals' FCF Margin changed N/A to 41218.49% in Q1 2025 from the same period last year, while for Sep 2025 it was 48855.17%, marking a year-over-year increase of 58002700.0%. This contributed to the annual value of 48019.06% for FY2024, which is 330328900.0% down from last year.
  • Latest data reveals that Inovio Pharmaceuticals reported FCF Margin of 41218.49% as of Q1 2025.
  • Over the past 5 years, Inovio Pharmaceuticals' FCF Margin peaked at 737.94% during Q3 2022, and registered a low of 41218.49% during Q1 2025.
  • For the 5-year period, Inovio Pharmaceuticals' FCF Margin averaged around 19807.48%, with its median value being 16807.62% (2024).
  • Over the last 5 years, Inovio Pharmaceuticals' FCF Margin had its largest YoY gain of 223434800bps in 2022, and its largest YoY loss of -246900400bps in 2022.
  • Over the past 5 years, Inovio Pharmaceuticals' FCF Margin (Quarter) stood at 4592.32% in 2021, then plummeted by -538bps to 29282.36% in 2022, then increased by 13bps to 25597.2% in 2023, then surged by 34bps to 16807.62% in 2024, then tumbled by -145bps to 41218.49% in 2025.
  • Its FCF Margin stands at 41218.49% for Q1 2025, versus 16807.62% for Q4 2024 and 28040.54% for Q2 2024.